Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2013

01-06-2013 | Healthcare Policy and Outcomes

Readmission After Pancreatic Resection is not an Appropriate Measure of Quality

Authors: Irmina Gawlas, BA, Monica Sethi, MD, Megan Winner, MD, MS, Irene Epelboym, MD, James L. Lee, MD, Beth A. Schrope, MD, PhD, John A. Chabot, MD, John D. Allendorf, MD

Published in: Annals of Surgical Oncology | Issue 6/2013

Login to get access

Abstract

Background

Hospital readmission has been proposed as a metric for quality of medical and surgical care. We examined our institutional experience with readmission after pancreatic resection, and assessed factors predictive of readmission.

Methods

We reviewed 787 pancreatic resections performed at a single institution between 2006 and 2010. Univariate and multivariate logistic regression models were used to assess the relationships between preoperative and postoperative characteristics and readmission. Reasons for hospital readmission were examined in detail.

Results

We found the 30-day readmission rate after pancreatic resection to be 11.6 %. In univariate analysis, young age, pancreaticoduodenectomy versus other operations, open versus laparoscopic technique, fistula formation, the need for reoperation, and any complication during the index hospitalization were predictive of readmission. In multivariate analysis, only young age and postoperative complication were predictive of readmission. Vascular resection, postoperative ICU care, length of stay, and discharge disposition were not associated with readmission. The most common reasons for readmission were leaks, fistulas, abscesses, and wound infections (45.1 %), delayed gastric emptying (12.1 %), venous thrombosis (7.7 %), and GI bleeding (7.7 %).

Conclusions

We found the vast majority of readmissions after pancreatic resection were to manage complications related to the operation and were not due to poor coordination of care or poor discharge planning. Because evidence-based measures to prevent these surgical complications do not exist, we cannot support the use of readmission rates themselves as a quality indicator after pancreatic surgery.
Appendix
Available only for authorised users
Literature
2.
go back to reference “Medicaid Program; Payment adjustment for provider-preventable conditions including health care-acquired conditions.” Federal Register Vol. 76, No. 108. 6 Jun 2011, pp 32816–38. “Medicaid Program; Payment adjustment for provider-preventable conditions including health care-acquired conditions.” Federal Register Vol. 76, No. 108. 6 Jun 2011, pp 32816–38.
3.
go back to reference Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10:1243–52; discussion 1252–3. Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10:1243–52; discussion 1252–3.
4.
go back to reference Reddy DM, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13:1963–74; discussion 1974–5. Reddy DM, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13:1963–74; discussion 1974–5.
5.
go back to reference Grewal SS, McClaine RJ, Schmulewitz N, et al. Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford). 2011;13:869–75.CrossRef Grewal SS, McClaine RJ, Schmulewitz N, et al. Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford). 2011;13:869–75.CrossRef
6.
go back to reference Kent TS, Sachs TE, Callery MP, Vollmer CM Jr. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213:515–23.PubMedCrossRef Kent TS, Sachs TE, Callery MP, Vollmer CM Jr. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213:515–23.PubMedCrossRef
7.
go back to reference DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, Clavien PA. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931–7; discussion 937–9. DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, Clavien PA. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931–7; discussion 937–9.
8.
go back to reference Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef
9.
go back to reference Brown RE, Qadan M, Martin RC 2nd, Polk HC Jr. The evolving importance of readmission data to the practicing surgeon. J Am Coll Surg. 2010;211:558–60.PubMedCrossRef Brown RE, Qadan M, Martin RC 2nd, Polk HC Jr. The evolving importance of readmission data to the practicing surgeon. J Am Coll Surg. 2010;211:558–60.PubMedCrossRef
10.
11.
go back to reference Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.PubMedCrossRef Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.PubMedCrossRef
12.
go back to reference Makni A, Bedioui H, Jouini M, et al. Pancreaticojejunostomy vs. pancreaticogastrostomy following pancreaticoduodenectomy: results of comparative study. Minerva Chir. 2011;66:295–302.PubMed Makni A, Bedioui H, Jouini M, et al. Pancreaticojejunostomy vs. pancreaticogastrostomy following pancreaticoduodenectomy: results of comparative study. Minerva Chir. 2011;66:295–302.PubMed
13.
go back to reference Pecorelli N, Balzano G, Capretti G, Zerbi A, Di Carlo V, Braga M. Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital. J Gastrointest Surg. 2012;16:518–23.PubMedCrossRef Pecorelli N, Balzano G, Capretti G, Zerbi A, Di Carlo V, Braga M. Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital. J Gastrointest Surg. 2012;16:518–23.PubMedCrossRef
14.
go back to reference Traverso LW, Hashimoto Y. Delayed gastric emptying: the state of the highest level of evidence. J Hepatobiliary Pancreat Surg. 2008;15:262–9.PubMedCrossRef Traverso LW, Hashimoto Y. Delayed gastric emptying: the state of the highest level of evidence. J Hepatobiliary Pancreat Surg. 2008;15:262–9.PubMedCrossRef
15.
go back to reference Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232:419–29.PubMedCrossRef Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232:419–29.PubMedCrossRef
16.
go back to reference Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg. 2003;196:954–64.PubMedCrossRef Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg. 2003;196:954–64.PubMedCrossRef
17.
go back to reference Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–72; discussion 772–4. Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–72; discussion 772–4.
18.
go back to reference Fazio VW, Cohen Z, Fleshman JW, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1–11.PubMedCrossRef Fazio VW, Cohen Z, Fleshman JW, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1–11.PubMedCrossRef
Metadata
Title
Readmission After Pancreatic Resection is not an Appropriate Measure of Quality
Authors
Irmina Gawlas, BA
Monica Sethi, MD
Megan Winner, MD, MS
Irene Epelboym, MD
James L. Lee, MD
Beth A. Schrope, MD, PhD
John A. Chabot, MD
John D. Allendorf, MD
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2763-y

Other articles of this Issue 6/2013

Annals of Surgical Oncology 6/2013 Go to the issue

Healthcare Policy and Outcomes

Comprehensive Databases: A Cautionary Note